Next Generation Antidepressants: Moving Beyond Monoamines to Discover Novel Treatment Strategies for Mood Disorders. Edited by Chad E. Beyer & Stephen M. Stahl. Cambridge University Press. 2010. £50 (hb). 150pp. ISBN: 9780521760584
Autor: | Daniel J. Smith |
---|---|
Rok vydání: | 2011 |
Předmět: | |
Zdroj: | British Journal of Psychiatry. 198:499-499 |
ISSN: | 1472-1465 0007-1250 |
DOI: | 10.1192/bjp.bp.110.084376 |
Popis: | [⇓][1] ![Figure][2] In 2010, three major pharmaceutical companies (GlaxoSmithKline, AstraZeneca and MSD) announced that they would be stopping their UK-based research into new treatments for psychiatric and neurological disease. This is likely to have profound repercussions, not only for |
Databáze: | OpenAIRE |
Externí odkaz: |